FDA approves Wegovy pill for weight loss, the first daily oral medication of its kind
CBS News • • business
Key Points:
- The FDA approved the first daily oral obesity pill, Wegovy, made by Novo Nordisk, giving the company an advantage over Eli Lilly, whose oral obesity drug orforglipron is still under review.
- Both Wegovy and orforglipron are GLP-1 drugs that mimic a natural hormone to control appetite, with Wegovy pills expected to be available within weeks and potentially expanding access to obesity treatments.
- Clinical trials showed oral Wegovy users lost an average of 13.6% of their body weight over 15 months, comparable to injectable Wegovy, while Lilly’s orforglipron users lost 11.2% over 17 months; both are less effective than Lilly’s injectable Zep
